causes not stated by the regulator — e.g. “Erhöhte Nachfrage” (Germany)
Recent shortage history
Norway: resolved 10 Jul 2026 (began 15 Feb 2026)
Norway: resolved 18 Feb 2026 (began 30 Jan 2026)
Norway: resolved 10 Feb 2026 (began 15 Jan 2026)
Norway: resolved 18 Dec 2025 (began 27 Oct 2025)
Norway: resolved 22 Dec 2025 (began 20 Oct 2025)
Frequently asked questions
Is Tolterodintartrat currently in shortage?
Yes. As of the latest regulator updates, Tolterodintartrat has 4 active shortage notices across 1 country (Germany). Status is refreshed daily from official regulatory sources.
Why is Tolterodintartrat in shortage?
Regulators attribute the current Tolterodintartrat shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Tolterodintartrat shortage be resolved?
Regulator-estimated resolution dates currently range from 18 May 2026 to 3 Jan 2028, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Tolterodintartrat shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Tolterodintartrat status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.